Rogez-Florent Tiphaine, Foulon Catherine, Drucbert Anne-Sophie, Schifano Nadège, Six Perrine, Devassine Stéphanie, Depreux Patrick, Danzé Pierre-Marie, Goossens Laurence, Danel Cécile, Goossens Jean-François
Univ. Lille, EA 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000, Lille, France.
Univ. Lille, EA 7365, GRITA - Groupe de Recherche sur les formes Injectables et les Technologies Associées, F-59000, Lille, France; Univ. Lille, Plate-forme d'interactions moléculaires, F-59000, Lille, France.
J Pharm Biomed Anal. 2017 Apr 15;137:113-122. doi: 10.1016/j.jpba.2017.01.023. Epub 2017 Jan 9.
The aim of this study was to develop a method combining chiral separation and biophysical techniques to evaluate the enantioselective affinity of original sulfonamide derivatives towards their therapeutic target, the human carbonic anhydrase II (hACII). The first step consisted in the preparation of the enantiomers by chromatographic separation. The performances of HPLC and Supercritical Fluid Chromatography (SFC) were studied at the analytical scale by optimization of various experimental conditions using adsorbed polysaccharide chiral stationary phases (amylose AD-H and cellulose OD-H). Since SFC allowed obtaining higher enantioresolutions per time unit, it was selected for the semi-preparative scale and successfully used to isolate each enantiomer with a satisfactory enantiomeric purity (>98%). Secondly, microscale thermophoresis (MST) method and surface plasmon resonance (SPR) used as reference method were developed to measure potential enantioselective affinities of these enantiomers towards the hACII. The optimizations of both methods were performed using a reference compound, i.e. acetazolamide, which affinity for hCAII has previously been demonstrated. For all compounds, K values obtained using MST and SPR were in good agreement, leading to similar affinity scales despite both approaches totally differ (labeling for MST versus immobilization of the protein for SPR). The equilibrium dissociation constants of our original compounds for the hCAII were in the range 100-1000nM and an enantioselectivity was observed using the MST and SPR methods for the diarylpyrazole 2. Finally, by comparing the MST and SPR techniques, MST appears especially adapted for further screening of a series of sulfonamide derivatives due to the lower time required to estimate a binding constant while consuming as little hCAII as SPR.
本研究的目的是开发一种结合手性分离和生物物理技术的方法,以评估原始磺胺类衍生物对其治疗靶点——人碳酸酐酶II(hACII)的对映体选择性亲和力。第一步是通过色谱分离制备对映体。使用吸附多糖手性固定相(直链淀粉AD-H和纤维素OD-H),通过优化各种实验条件,在分析规模上研究了高效液相色谱(HPLC)和超临界流体色谱(SFC)的性能。由于SFC能够在单位时间内获得更高的对映体分辨率,因此被选择用于半制备规模,并成功用于分离每种对映体,对映体纯度令人满意(>98%)。其次,开发了微尺度热泳(MST)方法和用作参考方法的表面等离子体共振(SPR),以测量这些对映体对hACII的潜在对映体选择性亲和力。这两种方法的优化均使用参考化合物乙酰唑胺进行,其对hCAII的亲和力先前已得到证实。对于所有化合物,使用MST和SPR获得的K值吻合良好,尽管两种方法完全不同(MST为标记法,而SPR为蛋白质固定法),但仍得出了相似的亲和力尺度。我们原始化合物对hCAII的平衡解离常数在100 - 1000 nM范围内,使用MST和SPR方法观察到二芳基吡唑2具有对映体选择性。最后,通过比较MST和SPR技术,由于估计结合常数所需时间更短,同时消耗的hCAII与SPR一样少,MST似乎特别适合进一步筛选一系列磺胺类衍生物。